Ohar medikoa Oharra: Wikipediak ez du mediku aholkurik ematen . Tratamendua behar duzula uste baduzu, jo ezazu sendagilearengana.
Azido flufenamiko Formula kimikoa C14 H10 F3 NO2 SMILES kanonikoa 2D eredua MolView 3D eredua Mota konposatu kimiko Fusio-puntua 134 °C Masa molekularra 281,066 Da Elkarrekintza Anoctamin 1 (en) , Gap junction protein beta 7 (en) , Gap junction protein beta 2 (en) , gap junction protein beta 6 (en) , Gap junction protein gamma 3 (en) , Gap junction protein beta 4 (en) , Gap junction protein beta 3 (en) , Gap junction protein beta 5 (en) , Gap junction protein delta 3 (en) , Gap junction protein beta 1 (en) , Gap junction protein delta 2 (en) , Gap junction protein alpha 4 (en) , Gap junction protein alpha 5 (en) , Gap junction protein delta 4 (en) , Gap junction protein alpha 1 (en) , Gap junction protein gamma 1 (en) , Gap junction protein alpha 3 (en) , Gap junction protein gamma 2 (en) , Gap junction protein alpha 8 (en) , Gap junction protein alpha 9 (en) , Gap junction protein alpha 10 (en) , Pannexin 1 (en) , Pannexin 2 (en) , Pannexin 3 (en) , Transient receptor potential cation channel subfamily C member 5 (en) , Transient receptor potential cation channel subfamily M member 2 (en) , Transient receptor potential cation channel, subfamily M, member 4 (en) , Transient receptor potential cation channel subfamily M member 5 (en) eta Polycystin 2 like 1, transient receptor potential cation channel (en) Rola antiinflamatorio InChlKey LPEPZBJOKDYZAD-UHFFFAOYSA-N CAS zenbakia 530-78-9 ChemSpider 3254 PubChem 3371 Reaxys 1996069 Gmelin 42638 ChEBI 1327188 ChEMBL CHEMBL23588 EC zenbakia 208-494-1 ECHA 100.007.723 MeSH D005439 RxNorm 4453 Human Metabolome Database HMDB0252331 UNII 60GCX7Y6BH KEGG D01581 PDB Ligand FLF
Azido flufenamikoa [1] antiinflamatorio ez esteroideo familiako botika da. Azido fenamiko edo fenamatoaren deribatua,[2] analgesiko eta antipiretikoa ere bada.
2020ko urrian, FDAk medikamentuaren etiketa hanturaren aurkako sendagai ez esteroide guztietarako eguneratzea eskatu zuen, jaiotzeagatiko giltzurrun-arazoen arriskua deskribatzeko, likido amniotikoaren maila baxuan gertatzen baitira.[3]